Ana Gutierrez used bubbly to battle the rising tide of her lapsed Catholic guilt and channel her inner Frida Kahlo.

Immersive exhibition reimagines art through multi-sensory experience to improve the accessibility of visual arts for those with visual impairments.Blending technology, innovation, and creativity, ...

Retail investors took advantage of the market selloff earlier this week by buying various technology stocks, including Nvidia ...

The notice offers Vanda an opportunity to request a hearing on the matter. Also Read: Over 200% Stock Upside – Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst In ...

After a series of strongly worded letters—one of which was addressed directly to Commissioner Robert Califf—the FDA has publicly laid out its reasoning for rejecting Vanda Pharmaceuticals’ ...

The FDA met resistance from a three-judge panel Wednesday over its decision to refuse approval of Vanda Pharmaceuticals Inc.’s jet lag disorder drug. At issue in arguments before the US Court of ...

Rarely does the FDA pub­licly re­lease its rea­son­ing for re­ject­ing a po­ten­tial new drug. But for DC-based Van­da Phar­ma­ceu­ti­cals’ gas­tro­pare­sis drug, the FDA on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

AstraZeneca CFO Aradhana Sarin promised Phase III readouts and revenue growth in 2025 despite ongoing investigations of its Chinese operations. Credit: Bloomberg/ Getty Images AstraZeneca says a ...

After Vanda Pharmaceuticals’ phase 3 miss and FDA rejection for its stomach disorder candidate, CEO Mihael Polymeropoulos, M.D., is calling out the regulatory agency for a “disturbing pattern ...

Artfully Walls Art that is carefully chosen and displayed can help pull the look of a room together (Credit: Artfully Walls) Imaginatively chosen and displayed art can both revive cherished ...

Vanda called the attention of FDA Commissioner Robert Califf to what it termed the “sentiment that the agency avoids public scrutiny of its decisions.” Vanda Pharmaceuticals on Wednesday sent a letter ...